Endocrine Abstracts

Introduction: The major cause of death and disability in patients with diabetes mellitus is atherosclerotic cardiovascular disease (ASCVD). Therefore, treatment guidelines specify strict target lipid levels for these patients. The aim of this study is to evaluate the adherence of diabetes mellitus type 1 and 2 patients (DM1 and DM2, respectively) with respect to the European and Swiss lipid treatment guidelines (ESC/EAS and AGLA, respectively).Methods: T...

A 58-year-old male patient presented with a 2 months history of bilateral frontotemporal headache, fatigue and impaired vision. Further exploration revealed short term memory losses, confusion, gait disturbances, decreased libido and erectile dysfunction. Radiological investigation showed a 4 cm pituitary mass with destruction of the upper clivus and left petrous apex associated with a 5 cm large suprasellar cyst bulging upward into the 3d ventricle with obstruction hydrocepha...

Objective: Cinacalcet, a calcimimetic that reduces parathyroid hormone (PTH) secretion and serum calcium (S-Ca) levels by increasing the sensitivity of calcium-sensing receptors has been introduced for the treatment of patients with persistent or recurrent primary hyperparathyroidism (PHPT). Within a prospective, non-interventional cohort study we identified patients with newly diagnosed PHPT who have been started on cinacalcet. Patient characteristics, treatment indications a...